Innovating Works

BIOMEDAL

Activa
GLUCHIRAL: Molecular chirality tools for the study of Gluten Immunogenic Peptides and Celiac Disease: Novel the... BIOMEDAL participó en un HORIZON EUROPE HORIZON-MSCA-2023-PF-01 Celiac disease (CD) is a systemic autoimmune disorder triggered by gluten consumption in genetically predisposed individuals, affecting a su...
2024-04-15 - 2028-02-29 | Financiado
Safeguard: Safeguarding European wild pollinators BIOMEDAL participó en un H2020 H2020-SC5-2018-2019-2020 Wild pollinators are a key part of European biodiversity and provide a wide range of benefits to crops, wild plants, and human wellbeing. In...
2021-05-14 - 2025-08-31 | Financiado
GIPTRAP: Therapeutic potential of recombinant antibodies to neutralize immunogenic peptides in celiac disease BIOMEDAL tramitó un H2020 H2020-MSCA-IF-2020 Celiac disease affects about 1% of the population worldwide. It is an autoimmune disease triggered by gluten intake in genetically predispos...
2021-04-16 - 2023-12-31 | Financiado
SOCRATES: European Training Network for the sustainable zero waste valorisation of critical metal containin... BIOMEDAL participó en un H2020 H2020-MSCA-ITN-2016 Unlike China, Russia or South Africa, the EU-28 Member States are not in the fortunate position of having vast, easily accessible ore deposi...
2016-08-11 - 2020-08-31 | Financiado
MABTOX: Generation and Evaluation of Next generation Antibody Toxin Conjugates for Cancer Therapy BIOMEDAL participó en un FP7 Therapeutic antibodies have transformed cancer therapy during the last decade, due to their high selectivity of targeting cancer cells in co...
Financiado
MAGICBULLET: Optimisation of treatment with off patent antimicrobial agents of ventilator associated pneumonia V... BIOMEDAL participó en un FP7 Background. Ventilator-associated pneumonia (VAP) is one of the most common and severe hospital-adquired infections, and multidrugresistant...
Financiado
INTENSO: Gaining Productivity Cost Efficiency and Sustainability in the Downstreaming Processing of Bio Prod... BIOMEDAL participó en un FP7 The European Life science and chemical industries increasingly depend on effi-cient, sustainable, and cost-effective bioprocessing platforms...
Financiado
ELECTROEXTRACTION: Protein electroextraction coupled to direct sorption a new route for primary recovery of intracell... BIOMEDAL participó en un FP7 This project proposes a new -highly efficient- method for intracellular protein recovery form yeast – electroextraction. Moreover, a novel b...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.